Prevention of ventilator-associated pneumonia: Bugs or drugs?

American Journal of Respiratory and Critical Care Medicine

Volumn 182, Issue 8, 2010, Pages 993-994

  Bonten, Marc J M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BIOLOGICAL MARKER; PROBIOTIC AGENT; PROCALCITONIN;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTIFICIAL VENTILATION; ASPIRATION; BACTERIAL COLONIZATION; BONE MARROW CELL; EDITORIAL; FEVER; HOSPITALIZATION; HUMAN; INFECTION RISK; INTENSIVE CARE UNIT; LACTOBACILLUS RHAMNOSUS; LENGTH OF STAY; LEUKOCYTOSIS; OUTCOME ASSESSMENT; PATIENT CARE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY DISTRESS; RESPIRATORY TRACT INFECTION; RISK REDUCTION; SURVIVAL RATE; THORAX RADIOGRAPHY; VENTILATOR ASSOCIATED PNEUMONIA;

ANTIBIOTIC PROPHYLAXIS; EVIDENCE-BASED MEDICINE; HUMANS; LACTOBACILLUS RHAMNOSUS; PNEUMONIA, VENTILATOR-ASSOCIATED; PROBIOTICS;

EID: 78049349014     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201007-1033ED     Document Type: Editorial

References (12)

1. Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, Moreno R, Lipman J, Gomersall C, Sakr Y, et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA 2009;302:2323-2329.
2. Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002;165:867-903.
3. Linssen CF, Bekers O, Drent M, Jacobs JA. C-reactive protein and procalcitonin concentrations in bronchoalveolar lavage fluid as a predictor of ventilator-associated pneumonia. Ann Clin Biochem 2008; 45:293-298.
4. Jung B, Embriaco N, Roux F, Forel JM, Demory D, Allardet-Servent J, Jaber S, La Scola B, Papazian L. Microbiological data, but not procalcitonin improve the accuracy of the clinical pulmonary infection score. Intensive Care Med 2010;36:790-798.
5. Fagon JY, Chastre J, Wolff M, Gervais C, Parer-Aubas S, Stephan F, Similowski T, Mercat A, Diehl JL, Sollet JP, et al. Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia. A randomized trial. Ann Intern Med 2000;132: 621-630. (Pubitemid 30217554)
6. Melsen WG, Rovers MM, Bonten MJ. Ventilator-associated pneumonia and mortality: a systematic review of observational studies. Crit Care Med 2009;37:2709-2718.
7. Schumacher M, Wangler M, Wolkewitz M, Beyersmann J. Attributable mortality due to nosocomial infections. A simple and useful application of multistate models. Methods Inf Med 2007;46:595-600.
8. Nguile-Makao M, Zahar JR, Francais A, Tabah A, Garrouste-Orgeas M, Allaouchiche B, Goldgran-Toledano D, Azoulay E, Adrie C, Jamali S, et al. Attributable mortality of ventilator-associated pneumonia: respective impact of main characteristics at ICU admission and VAP onset using conditional logistic regression and multi-state models. Intensive Care Med 2010;36:781-789.
9. Bonten MJ, Kollef MH, Hall JB. Risk factors for ventilator-associated pneumonia: from epidemiology to patient management. Clin Infect Dis 2004;38:1141-1149.
10. de Smet AM, Kluytmans JA, Cooper BS, Mascini EM, Benus RF, van der Werf TS, van der Hoeven JG, Pickkers P, Bogaers-Hofman D, van der Meer NJ, et al. Decontamination of the digestive tract and oropharynx in ICU patients. N Engl J Med 2009;360:20-31.
11. de Jonge E, Schultz MJ, Spanjaard L, Bossuyt PM, Vroom MB, Dankert J, Kesecioglu J. Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial. Lancet 2003;362:1011-1016.
12. Morrow LE, Kollef MH, Casale TB. Probiotic prophylaxis of ventilator-associated pneumonia: A blinded, randomized, controlled trial. Am J Respir Crit Care Med 2010;182:1058-1064.